Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Goodwill & Intangibles (2017 - 2025)

BeOne Medicines (BEIGF) has disclosed Goodwill & Intangibles for 9 consecutive years, with $62.7 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 22.72% to $62.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.7 million through Dec 2025, up 22.72% year-over-year, with the annual reading at $62.7 million for FY2025, 22.72% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $62.7 million at BeOne Medicines, down from $63.6 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $64.9 million in Q2 2025, with the low at $4.8 million in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $45.0 million, with a median of $48.5 million recorded in 2023.
  • The sharpest move saw Goodwill & Intangibles decreased 13.48% in 2021, then soared 851.73% in 2022.
  • Over 5 years, Goodwill & Intangibles stood at $46.7 million in 2021, then fell by 12.99% to $40.6 million in 2022, then skyrocketed by 40.68% to $57.1 million in 2023, then fell by 10.58% to $51.1 million in 2024, then rose by 22.72% to $62.7 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $62.7 million, $63.6 million, and $64.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.